Chlamydia pneumoniae infection in preeclampsia

Hypertension in Pregnancy

Volumn 29, Issue 4, 2010, Pages 468-477

  Xie, Fang ^a   Hu, Yuxiang ^a   Magee, Laura A ^a   Money, Deborah M ^a   Patrick, David M ^a,b   Brunham, Robert M ^a,b   Thomas, Eva ^a,b   Von Dadelszen, Peter ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Chlamydia pneumoniae; Data synthesis; GDNA; Preeclampsia; Serology

Indexed keywords

GENOMIC DNA; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ARTICLE; CASE CONTROL STUDY; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DATA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE DOSAGE; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; PREECLAMPSIA; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC;

EID: 77957323135     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950903242642     Document Type: Article

References (32)

1. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335(7627):974.
2. Melnik T. Preeclampsia identifies women at risk for cardiovascular disease. Preeclampsia foundation. 2006 October 27 (1-17).
3. Gagliardi RJ, Silveira DR, Caffaro RA, Santos VP, Caiaffa-Filho HH. Chlamydia pneumoniae and symptomatic carotid atherosclerotic plaque: A prospective study. Arq Neuropsiquiatr 2007;65(2 B): 385-389.
4. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352(16):1685-1695.
5. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350(9075):430-436.
6. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997;96(11):4095-4103.
7. Hu H, Pierce GN, Zhong G. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 1999;103(5):747-753.
8. Moazed TC, Campbell LA, Rosenfeld ME, Grayston JT, Kuo CC. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis 1999;180(1):238-241.
9. von Dadelszen P, Magee LA, Krajden M, Alasaly K, Popovska V, Devarakonda RM, et al. Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia. BJOG 2003;110(8):725-730.
10. Tondella ML, Talkington DF, Holloway BP, Dowell SF, Cowley K, Soriano-Gabarro M, et al. Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae. J Clin Microbiol 2002;40(2):575-583.
11. Goulis DG, Chappell L, Gibbs RG, Williams D, Dave JR, Taylor P, et al. Association of raised titres of antibodies to Chlamydia pneumoniae with a history of pre-eclampsia. BJOG 2005;112(3):299-305.
12. Karinen L, Leinonen M, Bloigu A, Paldanius M, Koskela P, Saikku P, et al. Maternal serum Chlamydia pneumoniae antibodies and CRP levels in women with preeclampsia and gestational hypertension. Hypertens Pregnancy 2008;27(2):143-158.
13. Teran E, Escudero C, Calle A. Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsia. Obstet Gynecol 2003;102(1):198-199.
14. Aral M, Guven MA, Kocturk SA. Chlamydia pneumoniae seropositivity in women with preeclampsia. Int J Gynaecol Obstet 2006;92(1):77-78.
15. Heine RP, Ness RB, Roberts JM. Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsia. Obstet Gynecol 2003;101(2):221-226.
16. Raynor BD, Bonney EA, Jang KT, Coto W, Garcia MS. Preeclampsia and Chlamydia pneumoniae: Is there a link? Hypertens Pregnancy 2004;23(2):129-134.
17. Sessa R, Di Pietro M, Schiavoni G, Petrucca A, Cipriani P, Zagaglia C, et al. Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease. Atherosclerosis 2007;195(1): e224-e230.
18. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180(2 Pt 1):499-506.
19. Grabczewska Z, Nartowicz E, Kubica J, Rosc D. Endothelial function parameters in patients with unstable angina and infection with Helicobacter pylori and Chlamydia pneumoniae. Eur J Intern Med 2006;17(5):339-342.
20. Krull M, Klucken AC, Wuppermann FN, Fuhrmann O, Magerl C, Seybold J, et al. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J Immunol 1999;162(8):4834-4841.
21. Heinemann M, Susa M, Simnacher U, Marre R, Essig A. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun 1996;64(11):4872-4875.
22. Kalvegren H, Andersson J, Grenegard M, Bengtsson T. Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors. Eur J Pharmacol 2007;566(1-3): 20-27.
23. Kol A, Libby P. The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations. Trends Cardiovasc Med 1998;8(5):191-199.
24. Kaukoranta-Tolvanen SS, Teppo AM, Laitinen K, Saikku P, Linnavuori K, Leinonen M. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog 1996;21(3):215-221.
25. von Dadelszen P, Magee LA. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand 2002;81(7):642-648.
26. Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 2008;198(1):7-22.
27. Carreiras M, Montagnani S, Layrisse Z. Preeclampsia: a multifactorial disease resulting from the interaction of the feto-maternal HLA genotype and HCMV infection. Am J Reprod Immunol 2002;48(3):176-183.
28. Magee LA, Helewa M, Moutquin JM, von Dadelszen P, Cardew S, Côté AM, et al. Diagnosis, evaluation and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008;30.
29. von Versen-Hoeynck FM, Hubel CA, Gallaher MJ, Gammill HS, Powers RW. Plasma levels of inflammatory markers neopterin, sialic acid, and c-reactive protein in pregnancy and preeclampsia. Am J Hypertens 2009;22(6):687-692.
30. Hubel CA, Powers RW, Snaedal S, Gammill HS, Ness RB, Roberts JM, et al. C-reactive protein is elevated 30 years after eclamptic pregnancy. Hypertension 2008;51(6):1499-1505.
31. Goswami D, Tannetta DS, Magee LA, Fuchisawa A, Redman CW, Sargent IL, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 2006;27(1):56-61.
32. von Dadelszen P, Watson RW, Noorwali F, Marshall JC, Parodo J, Farine D, et al. Maternal neutrophil apoptosis in normal pregnancy, preeclampsia, and normotensive intrauterine growth restriction. Am J Obstet Gynecol 1999;181(2):408-414.